Diagnostic strategies for healthcare- associated pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 30, Issue 1, 2009, Pages 36-45

  Polverino, Eva ^a   Torres, Antoni ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Diagnostic tests; Etiology in HCAP; HCAP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; CARBAMOYL PHOSPHATE SYNTHASE; ENDOTHELIN 1; PROADRENOMEDULLIN; PROCALCITONIN; VASOPRESSIN;

AGE DISTRIBUTION; ALCOHOLISM; BLOOD CULTURE; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; GRAM STAINING; HEALTHCARE ASSOCIATED PNEUMONIA; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; INFECTIOUS PNEUMONIA; LEGIONELLA; LENGTH OF STAY; LUNG LAVAGE; MICROBIOLOGICAL EXAMINATION; MORTALITY; NEUROLOGIC DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROLOGY; SPUTUM EXAMINATION; STREPTOCOCCUS PNEUMONIA; THORACOCENTESIS; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE PROGRESSION; HUMANS; PNEUMONIA; PROTEIN PRECURSORS; TERMINOLOGY AS TOPIC;

EID: 60549100883     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0028-1119807     Document Type: Review

References (99)

1. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-1399
2. Kollef MH, Shorr A, Tabak YP,Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care- associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-3862
3. Meehan TP, Chua-Reyes JM, Tate J, et al. Process of care performance, patient characteristics, and outcomes in elderly patients hospitalized with community-acquired or nursing home-acquired pneumonia. Chest 2000;117: 1378-1385
4. National Center for Health Statistics. Highlights of Trends in the Health of Older Americans: United States, 1994. Washington, DC: US Department of Health and Human Services; 1995
5. Reuben DB, Schnelle JF, Buchanan JL, et al. Primary care of long-stay nursing home residents: approaches of three health maintenance organizations. J Am Geriatr Soc 1999;47: 131-138
6. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
7. Mody L, Maheshwari S, Galecki A, Kauffman CA, Bradley SF. Indwelling device use and antibiotic resistance in nursing homes: identifying a high-risk group. J Am Geriatr Soc 2007; 55:1921-1926
8. Seenivasan MH, Yu VL, Muder RR. Legionnaires' disease in long-term care facilities: overview and proposed solutions. J Am Geriatr Soc 2005;53:875-880
9. Troy CJ, Peeling RW, Ellis AG, et al. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997;277:1214-1218
10. Berk SL. Bacterial pneumonia in the elderly: the observations of Sir William Osler in retrospect. J Am Geriatr Soc 1984; 32:683-685
11. Donowitz GR, Cox HL. Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med 2007;23: 515-534 vi
12. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-368
13. Fernandez-Sabe N, Carratala J, Roson B, et al. Community- acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 2003;82:159-169
14. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community- acquired pneumonia. Arch Intern Med 1997;157:1453-1459
15. Riquelme R, Torres A, El-Ebiary M, et al. Community- acquired pneumonia in the elderly. clinical and nutritional aspects. Am J Respir Crit Care Med 1997;156:1908-1914
16. Marrie TJ, Blanchard W. A comparison of nursing home- acquired pneumonia patients with patients with community- acquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc 1997;45:50-55
17. Roghmann MC, Warner J, Mackowiak PA. The relationship between age and fever magnitude. Am J Med Sci 2001; 322:68-70
18. Niederman MS, Brito V. Pneumonia in the older patient. Clin Chest Med 2007;28:751-771 vi
19. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003;124:328-336
20. Groher ME. Managing dysphagia in a chronic care setting: an introduction. Dysphagia 1990;5:59-60
21. Kayser-Jones J, Pengilly K. Dysphagia among nursing home residents. Geriatr Nurs 1999;20:77-82
22. Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001;161: 2378-2381
23. Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 1994;150:251-253
24. Feldman C. Pneumonia in the elderly. Clin Chest Med 1999;20:563-573
25. Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006;130:11-15
26. Metersky ML, Sweeney TA, Getzow MB, Siddiqui F, Nsa W, Bratzler DW. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? Chest 2006;130:16-21
27. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080-2084
28. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-644
29. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes- proceedings of the HCAP Summit. Clin Infect Dis 2008; 46(Suppl 4):S296-S334
30. El Solh AA, Sikka P, Ramadan F, Davies J. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001;163:645-651
31. Martinez-Moragon E, Garcia FL, Serra SB, Fernandez FE, Gomez BA, Julve PR. Community-acquired pneumonia among the elderly: differences between patients living at home and in nursing homes. Arch Bronconeumol 2004;40: 547-552
32. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Healthcare-associated pneumonia and community- acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-3573
33. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community- acquired pneumonia in adults. Clin Infect Dis 2007;44 (Suppl 2):S27-S72
34. Menendez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax 2008;63:447-452
35. Seppa Y, Bloigu A, Honkanen PO, Miettinen L, Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001; 161:2709-2713
36. Nylen ES, Snider RH Jr, Thompson KA, Rohatgi P, Becker KL. Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 1996;312:12-18
37. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007;30: 556-573
38. Christ-Crain M, Muller B. Procalcitonin and pneumonia: is it a useful marker? Curr Infect Dis Rep 2007;9:233-240
39. Ip M, Rainer TH, Lee N, et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 2007;59:131-136
40. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004;363:600-607
41. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006;174:84-93
42. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-538
43. Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008;31:349-355
44. Harbarth S, Holeckova K, Froidevaux C, et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402
45. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Proadrenomedullin to predict severity and outcome in community-acquired pneumonia. Crit Care 2006;10:R96
46. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005;9:R816-R824
47. Struck J, Uhlein M, Morgenthaler NG, et al. Release of the mitochondrial enzyme carbamoyl phosphate synthase under septic conditions. Shock 2005;23:533-538
48. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 2001;95:78-82
49. Glerant JC, Hellmuth D, Schmit JL, Ducroix JP, Jounieaux V. Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission. Respir Med 1999;93:208-212
50. Metersky ML, Ma A, Bratzler DW, Houck PM. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004;169:342-347
51. Campbell SG, Marrie TJ, Anstey R, Dickinson G, Ackroyd- Stolarz S. The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study. Chest 2003;123:1142-1150
52. Ramanujam P, Rathlev NK. Blood cultures do not change management in hospitalized patients with community- acquired pneumonia. Acad Emerg Med 2006;13:740-745
53. Murray PR, Baron EJ, Joergensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. 8th ed. Washington, DC: American Society for Microbiology; 2003
54. Wong LK, Barry AL, Horgan SM. Comparison of six different criteria for judging the acceptability of sputum specimens. J Clin Microbiol 1982;16:627-631
55. Reimer LG, Carroll KC. Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections. Clin Infect Dis 1998;26:742-748
56. Fishman JA, Roth RS, Zanzot E, Enos EJ, Ferraro MJ. Use of induced sputum specimens for microbiologic diagnosis of infections due to organisms other than Pneumocystis carinii. J Clin Microbiol 1994;32:131-134
57. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31:869-874
58. Sanyal S, Smith PR, Saha AC, Gupta S, Berkowitz L, Homel P. Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med 1999;160:346-348
59. Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med 2003;138:109-118
60. Fein AM. Pneumonia in the elderly: overview of diagnostic and therapeutic approaches. Clin Infect Dis 1999;28:726-729
61. Ewig S, Schlochtermeier M, Goke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002;121:1486-1492
62. Musher DM, Montoya R, Wanahita A. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004;39:165-169
63. El Solh A, Pineda L, Bouquin P, Mankowski C. Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers. BMC Geriatr 2006;6:12
64. El-Ebiary M, Torres A, Gonzalez J, et al. Quantitative cultures of endotracheal aspirates for the diagnosis of ventilator-associated pneumonia. Am Rev Respir Dis 1993;148:1552-1557
65. El Solh AA, Akinnusi ME, Pineda LA, Mankowski CR. Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia. Crit Care 2007;11:R57
66. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000;162:119-125
67. Ramirez P, Valencia M, Torres A. Bronchoalveolar lavage to diagnose respiratory infections. Semin Respir Crit Care Med 2007;28:525-533
68. El Solh AA, Aquilina AT, Dhillon RS, Ramadan F, Nowak P, Davies J. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med 2002;166:1038-1043
69. El Solh AA, Alhajjhasan A, Ramadan FH, Pineda LA. A comparative study of community- and nursing home- acquired empyema thoracis. J Am Geriatr Soc 2007;55:1847-1852
70. Murdoch DR. Diagnosis of Legionella infection. Clin Infect Dis 2003;36:64-69
71. Kupronis BA, Richards CL, Whitney CG. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003;51:1520-1525
72. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998;338:1861-1868
73. Tan CG, Ostrawski S, Bresnitz EA. A preventable outbreak of pneumococcal pneumonia among unvaccinated nursing home residents in New Jersey during 2001. Infect Control Hosp Epidemiol 2003;24:848-852
74. Phares CR, Russell E, Thigpen MC, et al. Legionnaires' disease among residents of a long-term care facility: the sentinel event in a community outbreak. Am J Infect Control 2007;35:319-323
75. Falsey AR, Walsh EE. Viral pneumonia in older adults. Clin Infect Dis 2006;42:518-524
76. File TM. Community-acquired pneumonia. Lancet 2003; 362:1991-2001
77. Lim WS, Macfarlane JT. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. Eur Respir J 2001;18:362-368
78. Falsey AR, Dallal GE, Formica MA, et al. Long-term care facilities: a cornucopia of viral pathogens. J Am Geriatr Soc 2008;56:1281-1285
79. Tambyah PA, Habib AG, Ng TM, Goh H, Kumarasinghe G. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually ''healthcare associated''. Infect Control Hosp Epidemiol 2003;24:436-438
80. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin- resistant Staphylococcus aureus infection. JAMA 2003;290: 2976-2984
81. Nakashima K, Tanaka T, Kramer MH, et al. Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000. Infect Control Hosp Epidemiol 2006;27:1171-1177
82. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17: 697-728
83. Blasi F, Cosentini R, Tarsia P, Capone P, Allegra L. Atypical pathogens and asthma: can they influence the natural history of the disease? Monaldi Arch Chest Dis 2001;56:276-280
84. Plouffe JF. Importance of atypical pathogens of community- acquired pneumonia. Clin Infect Dis 2000;31(Suppl 2):S35-S39
85. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004;24:171-181
86. Murdoch DR. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis 2003;36:1162-1170
87. Kumar S, Wang L, Fan J, et al. Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients using a multiplex reverse transcriptase PCR assay with manual (enzyme hybridization) or automated detection (electronic microarray). J Clin Microbiol 2008;46:3063-3072
88. Brittain-Long R, Nord S, Olofsson S, Westin J, Anderson LM, Lindh M. Multiplex real-time PCR for detection of respiratory tract infections. J Clin Virol 2008;41:53-56
89. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004;52:2010-2015
90. Greub G, Liaudet L, Wiesel P, Bettschart V, Schaller MD. Respiratory complications of gastroesophageal reflux associated with paraesophageal hiatal hernia. J Clin Gastroenterol 2003;37:129-131
91. Ruhl CE, Sonnenberg A, Everhart JE. Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol 2001;11:477-483
92. El Solh AA, Pietrantoni C, Bhat A, et al. Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 2004;126:1575-1582
93. Coulthwaite L, Verran J. Potential pathogenic aspects of denture plaque. Br J Biomed Sci 2007;64:180-189
94. Beal M, Chesson A, Garcia T, Caldito G, Stucker F, Nathan CA. A pilot study of quantitative aspiration in patients with symptoms of obstructive sleep apnea: comparison to a historic control group. Laryngoscope 2004;114: 965-968
95. Llombart M, Chiner E, Andreu AL, et al. Prevalence of sleep apnea syndrome in patients with community acquired pneumonia [abstract]. Am J Respir Crit Care 2007;175:A702
96. King P, Holdsworth S, Freezer N, Holmes P. Bronchiectasis. Intern Med J 2006;36:729-737
97. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS. Common variable immunodeficiency: a new look at an old disease. Lancet 2008;372(9637):489-502
98. Gudmundsson G, Gross TJ. Middle lobe syndrome. Am Fam Physician 1996;53:2547-2550
99. Casey KR. Neoplastic mimics of pneumonia. Semin Respir Infect 1995;10:131-142